Product
GABITRIL
1 clinical trial
1 indication
Indication
Generalized Anxiety DisorderClinical trial
A 12-Month, Open-Label, Flexible-Dosage Study to Evaluate the Safety of GABITRIL at Dosages up to 16mg/Day in Adults With Generalized Anxiety DisorderStatus: , Estimated PCD: 2005-02-01